Business
Baird Medical Highlights Strategic Engagement at 2026 J.P. Morgan Healthcare Conference
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful participation in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.
About this update from Baird Medical Investment Holdings Ltd
[{"type":"text","content":"NEW YORK, Jan. 20, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful participation in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.","length":345,"tagName":"p"},{"type":"image","alt":"Baird Medical (PRNewsfoto/Baird Medical LLC)","displaySize":"","headline":null,"caption":"Baird Medical (PRNewsfoto/Baird Medical LLC)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":58,"url":"https://media.zenfs.com/en/prnewswire.com/89184118f4af4c585e7c535395abe2bc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0DcKXI1awHhZus7cyztYjQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEwMjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/89184118f4af4c585e7c535395abe2bc","width":400,"height":58}},"href":"https://mma.prnewswire.com/media/2539350/Baird_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"During the conference week, the Company's leadership team, including U.S. CEO Mark Saxton, held a series of meetings with institutional investors and healthcare industry veterans. These discussions focused on Baird Medical's 2026 strategic priorities, specifically the acceleration of its U.S. commercial footprint and the continued adoption of its thyroid ablation technologies.","length":387,"tagName":"p","attribs":{}},{"type":"text","content":""Our interactions in San Francisco reaffirmed the market's interest in our differentiated MWA platform," said Mark Saxton, U.S. CEO of Baird Medical. "We appreciated the opportunity to align with the investment community on our vision for the year ahead, which remains centered on driving clinical excellence and sustainable growth."","length":357,"tagName":"p","attribs":{}},{"type":"text","content":"Following these productive engagements, Baird Medical remains focused on executing its operational roadmap to enhance shareholder value and expand patient access to its minimally invasive solutions.","length":198,"tagName":"p","attribs":{}},{"type":"text","content":"About Baird Medical ","length":19,"tagName":"p"},{"type":"text","content":"Baird Medical is a forward-thinking medical device company specializing in minimall...